JAMA Psychiatry

JAMA Psychiatry

@jamapsychiatry.com

JAMA Psychiatry is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. 🌐 JAMAPsychiatry.com

443 followers12 following374 posts

Among patients with major depressive disorder, #MachineLearning predicted relapse with moderate accuracy, but the best model used only clinical relapse risk factors. Multimodal data did not improve prediction. ja.ma/4Bp5IS4

A Veterans Crisis Line #CaringLetters intervention was not associated with changes in #Suicide mortality among high-risk veterans who contacted the crisis line, although the previous parent trial found greater health care use among recipients. ja.ma/4hVkx5S

💬 Viewpoint: Current laws governing #ArtificialIntelligence in mental health may be difficult to enforce because key terms such as therapy, self-help, companion chatbot, and intended use are not clearly defined. ja.ma/4s2IOf3

Online #SportsBetting legalization was associated with more mental health-related outpatient visits and prescription use, suggesting greater demand on the behavioral health system as gambling access expands. ja.ma/4zv4Gls

A context-sensitive road map for #MentalHealth system scale-up indicates that governance, supervision, referral pathways, monitoring, and local adaptation are necessary for sustainable implementation. ja.ma/4hqhhyY

💬 Viewpoint: In #Psychiatry, care for #Deaf and hard-of-hearing patients requires clinical competency because hearing loss, signed language, and social bluffing can complicate the Mental Status Examination and affect diagnosis. ja.ma/47cOyJh

💬 Viewpoint: A special collection in #Psychiatry highlights early-career investigators studying clinical equity, structural #MRI and machine learning, ultraprocessed foods and depression, and placental growth factor trajectories. ja.ma/4rrJolZ

In patients with #Depression and high #UltraprocessedFoods intake, a low-ultraprocessed-food diet was feasible and acceptable, and depressive and anxiety symptoms were lower during the intervention period vs a regular diet. ja.ma/4xIUhBI

Interview with Laura Fässler, MSc, author of Psychological Interventions Targeting Auditory Hallucinations in Persons With Psychotic Disorders: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD. ja.ma/4romkoa

Many studies using #Neurodivergent or #Neurodiverse terminology identified participants through self-report or self-identification, and some did not specify any diagnosis. Precise diagnostic descriptors may improve clinical research and practice. ja.ma/471eTKf

📝 Viewpoint: #Cannabis commercialization is a modifiable public health exposure shaped by policies on access, potency, labeling, and marketing. Regulating these features may reduce psychiatric risk beyond legalization status alone. 10.1001/jamapsychiatry.2026.2869

📝 Viewpoint: High-dose #psychedelic #clinicaltrials remain poorly masked, which limits isolation of pharmacological effects from expectancy effects. More aggressive active comparators and reduced disclosure may strengthen causal inference. ja.ma/4gX0swJ

Among women with #BulimiaNervosa, structural #MRI identified lower nucleus accumbens volume and lower temporal cortical surface area vs healthy control individuals, supporting altered reward and social cognition circuits. ja.ma/477nBql

💡 Special Communication: In psychiatry, #PolygenicScores, rare variant testing, and #Pharmacogenomics may have value when used selectively to inform diagnosis, prognosis, monitoring, and medication safety rather than population-wide screening. ja.ma/3UD8l1I

Among adults with serious mental illness, #GLP1 receptor agonists vs #SGLT2 inhibitors were associated with lower mortality and fewer major cardiovascular events, with greater absolute benefit in serious mental illness. ja.ma/4r3cmZy

💬 Viewpoint: Family-based care for #Psychosis may need to address the digital home, where #SocialMedia and #ArtificialIntelligence shape symptom interpretation, conflict, treatment beliefs, and relapse warning signs. ja.ma/4A0j7zd

The FDA approved gepirone extended release for #Depression based on 2 positive trials despite 11 negative or inconclusive trials, highlighting the agency's use of regulatory flexibility and trial-level statistical significance. ja.ma/4g6sYM8

ja.maAssessing Drug Efficacy After Multiple Negative TrialsThis Special Communication reviews the US Food and Drug Administration evaluation of 1 investigational drug (gepirone extended release) for major depressive disorder with conflicting evidence of benefit.

In a cohort study, #PolygenicScores identified more patients at risk for #ADHD, #Depression, and #Schizophrenia than recurrent copy number variants, while both methods were complementary for risk assessment in #Autism. ja.ma/4gBALkZ

ja.maVariants and Psychiatric Outcomes in the Context of Polygenic ScoresThis genetic association study evaluates the association of recurrent copy number variants and polygenic scores with genetic risk factors for psychiatric disorders in the population.

Individualized, connectivity-based targeting of accelerated transcranial magnetic stimulation produced significantly greater antidepressant effects than scalp-based targeting in adults with treatment-resistant #Depression. ja.ma/4hzMkdA

ja.maConnectivity- vs Scalp-Based Targeting of Accelerated TMS for DepressionThis randomized clinical trial estimates the effect size of connectivity- vs scalp-based targeting of accelerated transcranial magnetic stimulation for treatment-resistant depression.

JAMA Psychiatry reposted

JAMA Psychiatry reposted

JAMA Psychiatry reposted

JAMA Psychiatry reposted

Thresholds are necessary for clinical decisions, but how do we set them? This question always comes up as a challenge for the clinical utility of dimensional psychopathology models. Fortunately, there are principled solutions! Our new paper lays them out. Led by Yuliya Kotelnovika & Roman Kotov

JAMA Psychiatry@jamapsychiatry.com

Consideration of statistical, impairment, prediction, and cost-benefit approaches for clinical-decision thresholds in #Psychiatry may enhance risk assessment and treatment selection beyond diagnosis-based cutoffs. ja.ma/4fEIpcR

Among young adults at varying #ManiaRisk, greater left ventrolateral prefrontal cortex activation during reward expectancy was associated with lower delay discounting, consistent with greater sensitivity to reward value. ja.ma/45wROP5